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ABSTRACT
We propose and analyse a nonlinear mathematical model for the
transmissiondynamics of pneumonia disease in a population of vary-
ing size. The deterministic compartmental model is studied using
stability theory of differential equations. The effective reproduction
number is obtained and also the asymptotic stability conditions for
the disease free and as well as for the endemic equilibria are estab-
lished. The possibility of bifurcation of the model and the sensitivity
indices of the basic reproduction number to the key parameters
are determined. Using Pontryagin’s maximum principle, the optimal
control problem is formulated with three control strategies: namely
disease prevention through education, treatment and screening.
The cost-effectiveness analysis of the adopted control strategies
revealed that the combination of prevention and treatment is the
most cost-effective intervention strategies to combat thepneumonia
pandemic. Numerical simulation is performed and pertinent results
are displayed graphically.
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1. Introduction
In the report of WHO [18], ‘infectious diseases are the leading cause of death in Human
beings’. According to the fact sheet of WHO [18] sixteen percent of all deaths each year
are from infectious diseases that means over 9.5 million deaths annually attribute to infec-
tious diseases, with most of them in developing countries. From 9.5 million annual death,
‘Pneumonia and other respiratory infections cause about 2 million child deaths yearly in
developing countries’ [19]. If we compare infectious diseases such as Malaria, HIV/AIDS,
Measles and Pneumonia for under five-year children in Africa, pneumonia is the leading
cause of deaths [19]. According to Institute for Health Metrics and Evaluation [4], every
35 seconds a child dies from pneumonia.
In Ethiopia, pneumonia is one of the leading cause of death. The reported cases shows
that, it has been increasing aggregatively in the past 7 years (see Figure 1).
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Figure 1. Reported cases of Pneumonia disease in Ethiopia from 2009 to 2015.
A lot of scholars proposed models for understanding of infectious disease dynamics
and also for making quantitative predictions of different intervention strategies and their
effectiveness [10–13]. Very few essential research have been done on the dynamics of pneu-
monia have been done in the last decade. Some of them are, Melegaro et al. [8], Joseph
Emaline [5], Ssebuliba, [16] andOkaka et al. [9], proposed amodel on pneumonia dynam-
ics. Additionally, Ong’ala et al. [14] studied and estimated the basic reproductive number as
a random variable by first developing and analysing a deterministicmodel for transmission
patterns of pneumonia.
All the above studies have developed a deterministic as well as stochastic mathematical
model of pneumonia dynamics by subdividing the population into sub-classes of suscep-
tible, infectious, vaccinated, treated, carrier and recovered. But none of them considered
optimal control and cost-effectiveness strategies and also no study have been undertaken
by applying optimal control. This, therefore motivated us to undertake this study to ful-
fil this gap. To estimate some parameters demographic data were collected from Health
Minster of federal democratic republic of Ethiopia.
2. Model description and formulation
The model divides the total population into five sub-classes according to their disease sta-
tus. Susceptible (S), vaccinated (V ), carrier (C), infected (I) and recovered (R). The model
assumes that a fraction of the population has been vaccinated before the disease out break at
the rate of (p) and (1 − p) fraction of population susceptible. (We consider this model due
to the reason that, in African particularly in Ethiopian context all new born infants are not
taking Pneumococcal conjugate vaccine (PCV). Only thosemothers who are aware or who
stay around town or city will go to their nearby health centre to vaccinate their infants but
there are a lot of newborn left without vaccination).The Susceptible class is increased from
vaccinated class in which those individuals who are vaccinated but did not respond to vac-
cinationwithwaning rate ofφ and from recovered class inwhich those individualswho loss
their temporary immunity by δ rate. However, individuals from susceptible class move to
vaccinated class with vaccination rate ofϑ . The susceptible class is infected either by carrier
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Figure 2. Flow diagram of the model.
or symptomatically infected individuals with a force of infection λ = ξ((I(t) + ϒC(t))/N)
where, ξ = kτ , k is contact rate, τ is the probability that a contact is effective to cause
infection andϒ is transmission coefficient for the carrier. Ifϒ > 1 then, the carries infect
susceptible more likely than infective. Ifϒ = 1, then both carriers and infective have equal
chance to infect the susceptible, but ifϒ < 1 then the infective have good chance to infect
susceptible than carriers. The model assumes vaccination is not 100% effective, so vacci-
nated classes (V ) also have a chance of being infectious or carrier with small proportion
and the force of infection for the vaccinated class is λv = 	λ, where 0 ≤ 	 < 1 and 	 is the
proportion of the serotype not covered by the vaccine. Newly infected individuals by the
force of infection become either carrier with a probability of ρ to join the carrier class C or
move to the infected class I with probability of 1 − ρ. The carrier class can develop disease
symptom or can screen themselves and join the infected class with a rate of χ or recover
by gaining natural immunity at β rate. Individuals in the infected class move to recovered
compartment at a per capita rate of η by treatment, with treatment efficacy of q proportion
of individuals join the recovered class or join the carrier class with (1 − q) proportion by
adapting the treatment, or die from the disease at the rate α. In all compartments μ is the
natural mortality rate of individuals and also all the parameters are positive. The above
model description can be represented diagrammatically in Figure 2.
The above flow diagram can be written in to a system of five differential equations as
follows:
dS(t)
dt
= (1 − p)π + φV(t) + δR(t) − (μ + λ + ϑ)S(t),
dV(t)
dt
= pπ + ϑS(t) − (μ + 	λ + φ)V(t),
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dC(t)
dt
= ρλS(t) + ρ	λV(t) + (1 − q)ηI(t) − (μ + β + χ)C(t),
dI(t)
dt
= (1 − ρ)λS(t) + (1 − ρ)	λV(t) + χC(t) − (μ + α + η)I(t),
dR(t)
dt
= βC(t) + qηI(t) − (μ + δ)R(t). (1)
With initial condition S(0) = S0, V(0) = V0, I(0) = I0, C(0) = C0, R(0) = R0.
3. Model analysis
3.1. Invariant region
In this section, a region in which solutions of the model system are uniformly bounded is
the proper subset  ⊂ 5+.
The total population at any time t is given by N= S+V +C+I+R. and dN/dt = π −
μN − αI(t).
In the absence of mortality due to pneumonia equation, it becomes
dN
dt
≤ π − μN. (2)
By solving Equation (2), we obtain 0 ≤ N ≤ π/μ. Therefore, the feasible solution set of
the system equation (1) of the model remain in the region:
 =
{
(S,V ,C, I,R) ∈ 5+ : N ≤
π
μ
}
. (3)
3.2. Positivity of the solutions
In this section, to obtain the solution of the model is non-negative we stated and proved
the following theorem.
Theorem 3.1: let  = {(S,V ,C, I,R) ∈ 5+ : S0 > 0, V0 > 0, C0 > 0, I0 > 0, R0 > 0},
then the solution of {S,V ,C, I,R} are positive for t ≥ 0.
Proof: From the system of differential equation (1), let us take the first equation;
dS
dt
= (1 − pψ)π + φV + δR − (μ + λ + ϑ)S
⇒ dS
dt
≥ −(μ + λ + ϑ)S
⇒ dS
S
≥ −(μ + λ + ϑ) d(t)
⇒
∫
dS
S
≥ −
∫
(μ + λ + ϑ) d(t)
S(t) ≥ S0 exp−(μ + λ + ϑ)t ≥ 0.
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Similarly, we obtained
V(t) ≥ V0 exp−(μ + 	λ + φ)t ≥ 0.
C(t) ≥ C0 exp−(μ + β + χ)t ≥ 0.
I(t) ≥ I0 exp−(μ + α + η)t ≥ 0.
R(t) ≥ R0 exp−(μ + α + (1 − q)η)t ≥ 0. 
3.3. Disease-free equilibrium
In this section we obtain the equilibrium point at which the epidemic is eradicated from
the population. Letting the right-hand side of Equation (1) to zero and letting C= I=0,
leads to
E0 =
(
π
μ
℘,
π
μ
, 0, 0, 0
)
,
where ℘ = (μ − Pπμ + φ)/(μ + φ + ϑ) and  = (Pπμ + ϑ)/(μ + φ + ϑ).
3.4. The effective reproductive number (Reff)
In this section we obtained the threshold parameter that governs the spread of a disease
which is called the effective reproduction number is determined. To obtain the effective
reproduction number, we used the next-generationmatrix method so that it is the spectral
radius of the next-generation matrix [17] and we obtain
Reff = kτ
[
ρ(ϒ(μ + α + η) + χ)
(μ + β + χ)(μ + α + η) − χη(1 − q)
+ (1 − ρ)(ϒ(1 − q)η + (μ + β + χ))
(μ + β + χ)(μ + α + η) − χη(1 − q)
](
π
μ
℘ + 	 π
μ

)
. (4)
3.5. Local stability of disease-free equilibrium
Theorem 3.2: The disease-free equilibrium point is locally asymptotically stable if Reff < 1
and unstable if Reff > 1.
Proof: To prove local stability of disease-free equilibrium, we obtained the Jacobianmatrix
of the system (1) at the disease-free equilibrium E0:
J(S0,V0, 0, 0, 0) =
⎡
⎢⎢⎢⎢⎣
−(μ + ϕ) φ −aS0
ϕ −(μ + φ) −a	V0
0 0 ρaS0 + ρa	V0 − (μ + β + χ)
0 0 (1 − ρ)aS0 + (1 − ρ)a	V0 + χ
0 0 β
−bS0 δ
−b	V0 0
ρbS0 + ρb	V0 + (1 − q)η 0
(1 − ρ)bS0 + (1 − ρ)b	V0 − (μ + α + η) 0
qη −(μ + δ)
⎤
⎥⎥⎥⎥⎦ . (5)
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To obtain the eigenvalue of Equation (5),
∣∣∣∣∣∣∣∣∣∣
−(μ + ϕ) − λ φ −aS0
ϕ −(μ + φ) − λ −a	V0
0 0 [ρaS0 + ρa	V0 − (μ + β + χ)] − λ
0 0 (1 − ρ)aS0 + (1 − ρ)a	V0 + χ
0 0 β
−bS0 δ
−b	V0 0
ρbS0 + ρb	V0 + (1 − q)η 0
[(1 − ρ)bS0 + (1 − ρ)b	V0 − (μ + α + η)] − λ 0
qη −(μ + δ) − λ
∣∣∣∣∣∣∣∣∣∣
= 0
⇒ −(μ + ϕ) − λ
∣∣∣∣∣∣∣∣
−(μ + φ) − λ −a	V0
0 [ρaS0 + ρa	V0 − (μ + β + χ)] − λ
0 (1 − ρ)aS0 + (1 − ρ)a	V0 + χ
0 β
−b	V0 0
ρbS0 + ρb	V0 + (1 − q)η 0
[(1 − ρ)bS0 + (1 − ρ)b	V0 − (μ + α + η)] − λ 0
qη −(μ + δ) − λ
∣∣∣∣∣∣∣∣
− ϕ
∣∣∣∣∣∣∣∣
φ −aS0
0 [ρaS0 + ρa	V0 − (μ + β + χ)] − λ
0 (1 − ρ)aS0 + (1 − ρ)a	V0 + χ
0 β
−bS0 δ
ρbS0 + ρb	V0 + (1 − q)η 0
[(1 − ρ)bS0 + (1 − ρ)b	V0 − (μ + α + η)] − λ 0
qη −(μ + δ) − λ
∣∣∣∣∣∣∣∣
= 0
⇒ (−(μ + ϕ) − λ)[−(μ + φ) − λ]
∣∣∣∣∣∣
[ρaS0 + ρa	V0 − (μ + β + χ)] − λ
(1 − ρ)aS0 + (1 − ρ)a	V0 + χ
β
ρbS0 + ρb	V0 + (1 − q)η 0
[(1 − ρ)bS0 + (1 − ρ)b	V0 − (μ + α + η)] − λ 0
qη −(μ + δ) − λ
∣∣∣∣∣∣
− ϕφ
∣∣∣∣∣∣
[ρaS0 + ρa	V0 − (μ + β + χ)] − λ
(1 − ρ)aS0 + (1 − ρ)a	V0 + χ
β
ρbS0 + ρb	V0 + (1 − q)η 0
[(1 − ρ)bS0 + (1 − ρ)b	V0 − (μ + α + η)] − λ 0
qη −(μ + δ) − λ
∣∣∣∣∣∣ = 0
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⇒ (−(μ + ϕ) − λ)[−(μ + φ) − λ] − ϕφ
∣∣∣∣∣∣
[ρaS0 + ρa	V0 − (μ + β + χ)] − λ
(1 − ρ)aS0 + (1 − ρ)a	V0 + χ
β
ρbS0 + ρb	V0 + (1 − q)η 0
[(1 − ρ)bS0 + (1 − ρ)b	V0 − (μ + α + η)] − λ 0
qη −(μ + δ) − λ
∣∣∣∣∣∣ = 0
⇒ (−(μ + ϕ) − λ)[−(μ + φ) − λ] − ϕφ = 0 (6)
or ∣∣∣∣∣∣
[ρaS0 + ρa	V0 − (μ + β + χ)] − λ
(1 − ρ)aS0 + (1 − ρ)a	V0 + χ
β
ρbS0 + ρb	V0 + (1 − q)η 0
[(1 − ρ)bS0 + (1 − ρ)b	V0 − (μ + α + η)] − λ 0
qη −(μ + δ) − λ
∣∣∣∣∣∣ = 0, (7)
when we expand Equation (6)
λ2 + (2μ + φ + ϕ)λ + μ(μ + φ + ϕ). (8)
Then by Routh–Hurwitz criteria equation (8) have strictly negative root.
The determinant of Equation (7) can be obtained∣∣∣∣∣∣
ρa(S0 + 	V0) − (μ + β + χ) − λ ρb(S0 + 	V0) + (1 − q)η 0
(1 − ρ)a(S0 + 	V0) + χ (1 − ρ)b(S0 + 	V0) − (μ + α + η) − λ 0
β qη −(μ + δ) − λ
∣∣∣∣∣∣ = 0
⇒ −(μ + δ) − λ
∣∣∣∣ρa(S0 + 	V0) − (μ + β + χ) − λ ρb(S0 + 	V0) + (1 − q)η(1 − ρ)a(S0 + 	V0) + χ (1 − ρ)b(S0 + 	V0) − (μ + α + η) − λ
∣∣∣∣ = 0,
then
λ1 = −(μ + δ) < 0
and
(ρa(S0 + 	V0) − (μ + β + χ) − λ)((1 − ρ)b(S0 + 	V0) − (μ + α + η) − λ)
− ((1 − ρ)a(S0 + 	V0) + χ)(ρb(S0 + 	V0) + (1 − q)η) = 0, (9)
when we rearrange Equation (9), it becomes
λ2 + a1λ + a2 = 0,
where
a1 = (μ + β + χ) + (μ + α + η) − (ρa + (1 − ρ)b)(S0 + 	V0),
a2 = −(ρ(a(μ + α + η) + bχ) + (1 − ρ)(b(μ + β + χ) + a(1 − q)η))(S0 + 	V0)
− ((1 − q)χη − (μ + β + χ)(μ + α + η)).
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By Routh–Hurwitz criteria,
a1 > 0
means that,
(μ + β + χ) + (μ + α + η) > (ρa + (1 − ρ)b)(S0 + 	V0),
and also
a2 > 0
means that,
− (ρ(a(μ + α + η) + bχ) + (1 − ρ)(b(μ + β + χ) + a(1 − q)η))(S0 + 	V0)
− ((1 − q)χη − (μ + β + χ)(μ + α + η)) > 0
⇒ [(ρ(a(μ + α + η) + bχ) + (1 − ρ)(b(μ + β + χ) + a(1 − q)η))](S0 + 	V0)
< (μ + β + χ)(μ + α + η) − (1 − q)χη
⇒ [(ρ(a(μ + α + η) + bχ) + (1 − ρ)(b(μ + β + χ) + a(1 − q)η))]
(μ + β + χ)(μ + α + η) − (1 − q)χη (S0 + 	V0) < 1
⇒ Reff < 1,
Thus, the disease-free equilibrium is locally asymptotically stable if Reff < 1. 
3.6. The endemic equilibrium
The endemic equilibrium is denoted by E∗ and defined as a steady-state solutions for the
model (1). This can occur when there is a persistence of the disease. It can be obtained by
equating the system of Equation (1) to zero. Then we obtained
S∗ =
(μ + β + χ)((1 − ρ)(1 − q)η + ρ(μ + α + η))
− (1 − q)η((1 − ρ)(μ + β + χ) + ρχ)(μ + 	λ + φ)I∗
(((1 − ρ)(μ + β + χ) + ρχ)(μ + δ))ρλ(μ + 	λ + φ + 	ϑ) .
V∗ = pπ + ϑS
∗
μ + 	λ∗ + φ .
C∗ = (1 − ρ)(1 − q)η + ρ(μ + α + η)
(1 − ρ)(μ + β + χ) + ρχ I
∗,
I∗ =
A2λ∗∗(λ∗∗2	2D2 + λ∗∗μ	D2 + λ∗∗	D2 + λ∗∗	D2D6 + λ∗∗	D4 + μD2D6
+φD2D6 − λ∗∗D2 + D1D7 + D4D6)
A1(λ∗∗	D5)D7 − δλ∗∗3A5A2	2 + δλ∗∗2D6A5A2	 + δλ∗∗2D5A5	
+ δλ∗∗D6D5A5A2 + A1(λ∗∗	 + D5)λ∗∗
.
R∗ = β((1 − ρ)(1 − q)η + ρ(μ + α + η)) + ((1 − ρ)(μ + β + χ) + ρχ)qη
((1 − ρ)(μ + β + χ) + ρχ)(μ + δ) I
∗.
where
A1 = (μ + β + χ)((μ + α + η) − η(1 − q)),
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A2 = χρ + (1 − ρ)(μ + β + χ),
A3 = ρ(μ + δ)2(χ + (1 − ρ)(μ + β + χ)),
A4 = (χρ + (1 − ρ))(μ + δ),
A5 = (1 − ρ)η(1 − q) + ρ(μ + α + η) + (χρ + (1 − ρ)(μ + β + χ))qη,
D1 = 	pπ ,
D2 = A3(1 − p)π ,
D4 = A3φpπ ,
D5 = μ + φ,
D6 = 	ϑ + μ + φ,
D7 = A4φϑ − μ − ϑ .
Hence E∗ = (S∗,V∗,C∗, I∗,R∗) is the endemic equilibrium of the model 1.
Lemma 3.3: For Reff > 1 a unique endemic equilibrium point E∗ exist and no endemic
equilibrium otherwise.
Proof: For the disease to endemic, dC/dt > 0 and dI/dt > 0, that is:
dC(t)
dt
= ρλS(t) + ρ	λV(t) + (1 − q)ηI(t) − (μ + β + χ)C(t) > 0,
dI(t)
dt
= (1 − ρ)λS(t) + (1 − ρ)	λV(t) + χC(t) − (μ + α + η)I(t) > 0.
(10)
From the second inequality of Equation (10),
(μ + α + η)I(t) < (1 − ρ)λS(t) + (1 − ρ)	λV(t) + χC(t)
⇒ I <
(1 − ρ)ξ
(
I(t)+ϒC(t)
N (S + 	V) + χC
(μ + α + η)
From the fact (S + 	V)/N ≤ 1,
I <
(1 − ρ)ξ I(t) + (1 − ρ)ξϒC(t) + χC
(μ + α + η) . (11)
From the first inequality of Equation (10),
(μ + β + χ)C(t) < ρλS(t) + ρ	λV(t) + (1 − q)ηI(t)
⇒ C <
ρξ
(
I(t)+ϒC(t)
N (S + 	V) + (1 − q)ηI(t)
(μ + β + χ) .
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From the fact (S + 	V)/N ≤ 1,
C <
ρξ I(t) + (1 − q)ηI(t)
(μ + β + χ) − ρξϒ . (12)
By substituting Equation (12) into Equation (11) we can get,
I <
(1 − ρ)ξ I((μ + β + χ) − ρξϒ) + (1 − ρ)ξϒ(ρξ I + (1 − q)ηI) + χ(ρξ I + (1 − q)ηI)
(μ + α + η)(μ + β + χ − ρξϒ) .
Then, by rearranging and cancelling of I in both sides, we can get
1 < ξ
[
ρ(ϒ(μ + α + η) + χ)
(μ + β + χ)(μ + α + η) − χη(1 − q) +
(1 − ρ)(ϒ(1 − q)η + (μ + β + χ))
(μ + β + χ)(μ + α + η) − χη(1 − q)
]
≤ ξ
[
ρ(ϒ(μ + α + η) + χ)
(μ + β + χ)(μ + α + η) − χη(1 − q) +
(1 − ρ)(ϒ(1 − q)η + (μ + β + χ))
(μ + β + χ)(μ + α + η) − χη(1 − q)
]
×
(
π
μ
℘ + 	 π
μ

)
= Reff (13)
⇒ 1 < Reff .
Thus a unique endemic equilibrium exist when Reff > 1. 
Using expression for I∗ in the endemic equilibrium, we plot Figure 10, that shows there
is a backward bifurcation. We used a set of estimated parameters in Table 2. The figure
reflects the co-existence of the disease free with endemic equilibrium.
3.7. Local stability of the endemic equilibrium
Theorem 3.4: If Reff > 1 then the endemic equilibrium E∗ of system (1) is locally asymptot-
ically stable in .
Proof: To Prove the local stability of endemic equilibrium, we obtain the Jacobian matrix
at endemic equilibrium in Equation (14):
JE∗ = J(S∗,V∗,C∗,C∗,R∗)
=
⎡
⎢⎢⎢⎢⎣
−(μ + λ¯ + ϕ) φ 0 0 δ
ϕ −(μ + 	λ¯ + φ) 0 0 0
ρλ¯ ρ	λ¯ −(μ + β + χ) (1 − q)η 0
(1 − ρ)λ¯ (1 − ρ)	λ¯ χ −(μ + α + η) 0
0 0 β qη −(μ + δ)
⎤
⎥⎥⎥⎥⎦ .
(14)
The characteristic polynomial of Equation (14) in terms of force of infection is obtained as
P(λ) = λ5 + Z1λ4 + Z2λ3 + Z3λ2 + Z4λ + Z5,
where
Z1 = k4 + h3 + h4,
Z2 = k5 + k4(h3 + h4) − k1,
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Z3 = k3 + k4k5 − k1(h3 + h4) − βδρλ¯,
Z4 = k3(h3 + h4) − (k1k5 + k6δρλ¯ + βk7),
Z5 = k6k7 − k3k5.
For,
K7 = δϕρ	λ¯ + δρh2λ¯ + δρ	λ¯2,
k6 = χqη + βh4,
k5 = h3h4 − χ(1 − q)η,
k4 = h5 + k2,
k3 = h5(k1 + k2),
k2 = h1 + h2 + λ¯ + 	λ¯ − (1 − ρ)λ¯,
k1 = (h1 + λ¯)(h2 + 	λ¯) − (φϕ + ϕ(1 − ρ)	λ¯ + (1 − ρ)λ¯h2 + (1 − ρ)	λ¯2),
λ¯ is the force of infection evaluated at endemic equilibrium.
According to the Routh–Hurwitz criterion, for Reff > 1, the endemic equilibrium (E∗)
is locally asymptotically stable if,
Z1 > 0,Z2 > 0,Z3 > 0,Z4 > 0,Z5 > 0,
Z1Z2Z3 > Z32 + Z12Z4,
(Z1Z4 − Z5)(Z1Z2Z3 − Z32 − Z12Z4) > Z5(Z1Z2 − Z3)2 + Z1Z52. 
3.8. The global stability of the endemic equilibrium
Theorem 3.5: If Reff > 1, the endemic equilibrium E∗ of the model (1) is globally asymptot-
ically stable.
Proof: To prove the global asymptotic stability of the endemic equilibrium, we use the
method of Lyapunov functions.
Define.
L(S∗,V∗,C∗, I∗,R∗) =
(
S − S∗ − S∗lnS
∗
S
)
+
(
V − V∗ − V∗lnV
∗
V
)
+
(
C − C∗ − C∗lnC
∗
C
)
+
(
I − I∗ − I∗ln I
∗
I
)
+
(
R − R∗ − R∗lnR
∗
R
)
.
By direct calculating the derivative of L along the solution of Equation (1), we have
dL
dt
=
(
S − S∗
S
)
dS
dt
+
(
V − V∗
V
)
dV
dt
+
(
C − C∗
C
)
dC
dt
+
(
I − I∗
I
)
dI
dt
+
(
R − R∗
R
)
dR
dt
.
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dL
dt
=
(
S − S∗
S
)
[(1 − p)π + φV + δR − (μ + λ + ϑ)S]
+
(
V − V∗
V
)
[pπ + ϑS − (μ + 	λ + φ)V]
+
(
C − C∗
C
)
[ρλS + ρ	λV + (1 − q)ηI − (μ + β + χ)C]
+
(
I − I∗
I
)
[(1 − ρ)λS + (1 − ρ)	λV + χC − (μ + α + η)I]
+
(
R − R∗
R
)
[βC + qηI − (μ + δ)R].
dL
dt
= π + φV − φV∗ + δR − δR∗ − πS
∗
S
− PπS
∗
S
− φVS
∗
S
+ φV
∗S∗
S
− δRS
∗
S
+ δR
∗S∗
S
+ χC − χC∗
− (1 − ρ)λSI
∗
I
+ (1 − ρ)λS
∗I∗
I
− (1 − ρ)	λVI
∗
I
+ (1 − ρ)	λV
∗I∗
I
− χCI
∗
I
+ χC
∗I∗
I
+ (1 − q)ηI − (1 − q)ηI∗ − ρλSC
∗
C
+ ρλS
∗C∗
C
− ρ	λVC
∗
C
+ ρ	λV
∗C∗
C
− (1 − q)ηIC
∗
C
+ (1 − q)ηI
∗C∗
C
+ βC − βC∗ + qηI − qηI∗
− βCR
∗
R
+ βC
∗R∗
R
− qηIR
∗
R
+ qηI
∗R∗
R
+ ϕS − ϕS∗ − PπV
∗
V
− ϕSV
∗
V
+ ϕS
∗V∗
V
+ λS − λS∗ + 	λV − 	λV∗ − (V − V
∗)2
V
[μ + 	λ + φ]
− (I − I
∗)2
I
[μ + α + η] − (S − S
∗)2
S
[μ + λ + ϕ]
− (C − C
∗)2
C
[μ + β + χ] − (R − R
∗)2
R
[μ + δ]. (15)
Thus collecting positive terms together and negative terms together from Equation (15)
leads to
dL
dt
= Q − K,
where
Q = π + φV + δR + φV
∗S∗
S
+ δR
∗S∗
S
+ χC + (1 − ρ)λS
∗I∗
I
+ (1 − ρ)	λV
∗I∗
I
+ χC
∗I∗
I
+ (1 − q)ηI + ρλS
∗C∗
C
+ ρ	λV
∗C∗
C
+ (1 − q)ηI
∗C∗
C
+ βC
+ qη + βC
∗R∗
R
+ qηI
∗R∗
R
+ ϕS + ϕS
∗V∗
V
+ λS + 	λV
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K = φV∗ + πS
∗
S
+ PπS
∗
S
+ φVS
∗
S
+ δRS
∗
S
+ χC∗ + (1 − ρ)λSI
∗
I
+ (1 − ρ)	λVI
∗
I
+ χCI
∗
I
+ (1 − q)ηI∗ + ρλSC
∗
C
+ ρ	λVC
∗
C
+ (1 − q)ηIC
∗
C
+ qηI∗ + βCR
∗
R
+ qηIR
∗
R
+ ϕS∗ + PπV
∗
V
+ ϕSV
∗
V
+ λS∗ + 	λV∗
+ (V − V
∗)2
V
[μ + 	λ + φ] + (I − I
∗)2
I
[μ + α + η] + (S − S
∗)2
S
[μ + λ + ϕ]
+ (C − C
∗)2
C
[μ + β + χ] + (R − R
∗)2
R
[μ + δ].
Thus if Q < K, then dL/dt ≤ 0;
Noting that dL/dt = 0 if and only if S = S∗, V = V∗, C = C∗, I = I∗, R = R∗
Therefore, the largest compact invariant set in {(S∗,V∗,C∗, I∗,R∗) ∈  : dL/dt = 0} is
the singleton E∗, where E∗ is the endemic equilibrium of the system (1).
By LaSalle’s invariant principle ([6], it implies that E∗ is globally asymptotically stable in
 if Q<K. 
4. Sensitivity analysis of themodel parameters
We carried out the sensitivity analysis to determine the model robustness to parameter
values. The normalized forward sensitivity index of a variable to a parameter is a ratio of
the relative change in the variable to the relative change in the parameter. If a variable is a
differentiable function of the parameter, the sensitivity index may be alternatively defined
using partial derivatives.
Definition: The normalized forward sensitivity index of a variable, u, which depends
differentiability on index of a parameter, p is defined as up = (∂u/∂p)(p/u)
From an explicit formula for (Reff ) in Equation (4), we derive an analytical expres-
sion for the sensitivity of Reff as 
Reff
p = (∂Reff/∂p)(p/Reff ) to each of the parameter
involved in (Reff ). For example, the sensitivity index of Reff with respect to k is 
Reff
k =
(∂Reff/∂k)(k/Reff ) = 1, other indices Reffτ , Reffp , Reffφ , Reffϑ , Reff	 , Reffχ , Reffq , Reffη ,

Reff
β , 
Reff
τ , 
Reff
ρ , 
Reff
μ , 
Reff
α where obtained and evaluated at, p = 0.6, φ = 0.001,
ϑ = 0.9, 	 = 0.4, χ = 0.00274, q = 0.5, η = 0.0238, β = 0.0115, k = 6, τ = 0.89,
ρ = 0.338, μ = 0.002, α = 0.33 to obtain the following results.
4.1. Interpretation of sensitivity indices
Table 1 shows the sensitivity indices of Reff to the parameters for the pneumonia model,
evaluated at the baseline parameter values given in Table 2. The parameters are ordered
frommost sensitive to least. The most sensitive parameter is the contact rate, and the least
sensitive parameter is the progression proportion of the disease. This result implies that,
when the parameters k, 	, τ , φ and χ are increased keeping other parameters constant,
they increase the value of Reff thus, they increase the endemicity of the disease as they have
positive indices. While the parameters χ , p, ϑ ,μ, α, ρ, β , η and q decrease the value of Reff
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Table 1. Sensitivity indices table.
Parameter symbol Sensitivity indices
k +ve
	 +ve
τ +ve
φ +ve
χ +ve
p −ve
ϑ −ve
μ −ve
α −ve
ρ −ve
β −ve
η −ve
q −ve
Table 2. Parameter values for the Pneumonia model.
Parameter symbol Value Source
k 0.5 Estimated
	 0.002 Emile.J,2012
τ 0.89–0.99 Jacob.O,2012
φ 0.0025 Emile.J,2012
χ 0.001–0.01096 per day Jacob.O,2012
p 0.2 Emile.J,2012
ϑ 0.008 Assumed
μ 0.01 Estimated
α 0.057 Estimated
ρ 0.05 Jacob.O,2012
β 0.0115 Jacob.O,2012
η 0.2 Jacob.O,2012
q 0.5–1 Jacob.O,2012
ϒ 1.2 Assumed
δ 0.1 Emile. J, 2012
 0.2 Assumed
when they are increased while keeping the other parameters constant, implying that they
decrease the endemicity of the disease as they have negative indices.
5. Extension of themodel into an optimal control
In this section, we apply optimal control strategies on themodel (1). This helped us to iden-
tify the best intervention strategies that helps to eradicate the disease in the specified time.
The optimal control model is an extension pneumonia model by including the following
three controls defined as
(i) u1 a prevention effort, that protect susceptible from contacting the disease.
(ii) u2 a treatment effort, to minimize infection by treating infectious.
(iii) u3 a screening effort,to help carriers to screen themselves.
After incorporating, u1, u2 and u3 in pneumonia model (1), we obtain the following
optimal control model of pneumonia:
dS
dt
= (1 − p)π + φV + δr − (1 − u1)ξ(ϒC + I)S
N
− (ϑ + μ)S,
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dV
dt
= pπ + ϑS − (1 − u1)ξ(ϒC + I)V
N
− (μ + φ)V ,
dC
dt
= ρ(1 − u1)ξ(ϒC + I)(εV + S)
N
+ (1 − q)(1 − u2)ηI − (u3 + χ)C − (μ + β)C,
dI
dt
= (1 − ρ)(1 − u1)ξ(ϒC + I)(εV + S)
N
+ (u3 + χ)C − (η + u2)I − (μ + α)I,
dR
dt
= βC + (u2 + qη)I − (μ + δ)R, (16)
To study the optimal levels of the controls, the control setU is Lebesguemeasurable and it is
defined asU = {(u1(t), u2(t), u3(t)) : 0 ≤ u1 < 1, 0 ≤ u2 < 1, 0 ≤ u3 < 1, 0 ≤ t ≤ T}.
Our aim is to obtain a control u and S,V,C,I and R that minimize the proposed objec-
tive function J and the form of the objective functional is taken in line with literature on
epidemic models [1], given by
J = min
u1,u2,u3
∫ tf
0
(
b1C + b2I + 12
3∑
i=1
wiu2i
)
dt. (17)
where b1, b2 and wi are positive. The expression 12wiu
2
i represents cost which is associated
with the controls ui.The form is quadratic because we assume that costs are nonlinear in
its nature. Our aim is to minimize the number of carriers, infectives and costs. Thus, we
seek to find an optimal triple controls (u∗1, u
∗
2, u
∗
3) such that
J(u∗1, u
∗
2, u
∗
3) = min{J(u1, u2, u3)/ui ∈ U},
where U = {(u1, u2, u3)/ each ui is measurable with 0 ≤ ui < 1 for 0 ≤ t ≤ tf .
5.1. The Hamiltonian and optimality system
By using the principle of Pontryagin et al. [15], ‘Pontryagin’s Maximum Principle Pontrya-
gin’, we got the necessary conditions which is satisfied by optimal pair. Therefore, by this
principle, we obtained a Hamiltonian (H) defined as
H(S,V ,C, I,R, t) = L(C, I, u1, u2, u3, t) + λ1 dsdt + λ2
dV
dt
+ λ3 dCdt + λ4
dI
dt
+ λ5 dRdt ,
where L(C, I, u1, u2, u3, t) = b1C + b2I + 12
∑3
i=1 wiu2i , λi, i = 1, 2, 3, 4, 5 are the adjoint
variable functions to be determined suitably by applying Pontryagin’s maximal principle
[15] and also using [3] for existence of the optimal control pairs.
Theorem 5.1: For an optimal control set u1, u2, u3 that minimizes J over U, there is an
adjoint variables, λ1, . . . , λ5 such that:
dλ1
dt
= −
(
− (1 − u1)ξ(ϒ C + I)
N
− ϑ − μ
)
λ1 − ϑλ2 − ρ(1 − u1)ξ(ϒc + i)λ3N
− (1 − ρ)(1 − u1)ξ(ϒC + I)λ4
N
,
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dλ2
dt
= −φλ1 −
(
− (1 − u1)ξ(ϒC + I)
N
− μ − φ
)
λ2 − ρ(1 − u1)ξ(ϒC + I)ελ3N
− (1 − ρ)(1 − u1)ξ(ϒC + I)	λ4
N
,
dλ3
dt
= (1 − u1)ξϒSλ1
N
+ (1 − u1)ξϒVλ2
N
−
(
ρ(1 − u1)ξϒ(	V + S)
N
− u3 − χ − μ − β
)
λ3
−
(
(1 − ρ)(1 − u1)ξϒ(	V + S)
N
+ u3 + χ
)
λ4 − βλ5 − b1,
dλ4
dt
= (1 − u1)ξSλ1
N
+ (1 − u1)ξVλ2
N
−
(
ρ(1 − u1)ξ(	V + S)
N
+ (1 − q)(1 − u2)η
)
λ3
−
(
(1 − ρ)(1 − u1)ξ(εV + S)
N
− η − u2 − μ − α
)
λ4 − (ηq + u2)λ5 − b2,
dλ5
dt
= −δλ1 − (−μ − δ)λ5. (18)
With transversality conditions, λi(tf ) = 0, i = 1, . . . , 5.
Furthermore, we obtain the control set (u∗1, u
∗
2, u
∗
3) characterized by
u∗1(t) = max{0,min(1,1)},
u∗2(t) = max{0,min(1,2)},
u∗3(t) = max{0,min(1,3)},
where,
1 = ξ(σC + I)(ρVελ3 − ρVελ4 + ρSλ3 − ρSλ4 + Vελ4 − Vλ1 + Sλ4 − Vλ2)Nw1 ,
2 = − I(ηqλ3 − ηλ3 − λ4 + λ5)w2 ,
3 = C(λ3 − λ4)w3 .
Proof: The form of the adjoint equation and transversality conditions are standard results
from Pontryagin’s maximum principle [15]. We differentiate Hamiltonian 5.1 with respect
to states S, V, C, I and R, respectively, and then the adjoint system can be written as
dλ1(t)
dt
= −dH
dS
−
(
− (1 − u1)ξ(ϒC + I)
N
− ϑ − μ
)
λ1 − ϑλ2
− ρ(1 − u1)ξ(ϒC + I)λ3
N
− (1 − ρ)(1 − u1)ξ(ϒC + I)λ4
N
,
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dλ2
dt
= −dH
dV
= −φλ1 −
(
− (1 − u1)ξ(ϒC + I)
N
− μ − φ
)
λ2
− ρ(1 − u1)ξ(ϒC + I)ελ3
N
− (1 − ρ)(1 − u1)ξ(ϒC + I)	λ4
N
,
dλ3
dt
= −dH
dC
= (1 − u1)ξϒSλ1
N
+ (1 − u1)ξϒVλ2
N
−
(
ρ(1 − u1)ξϒ(	V + S)
N
− u3 − χ − μ − β
)
λ3
−
(
(1 − ρ)(1 − u1)ξϒ(	V + S)
N
+ u3 + χ
)
λ4 − βλ5 − b1,
dλ4
dt
= −dH
dt
= (1 − u1)ξSλ1
N
+ (1 − u1)ξVλ2
N
−
(
ρ(1 − u1)ξ(	V + S)
N
+ (1 − q)(1 − u2)η
)
λ3
−
(
(1 − ρ)(1 − u1)ξ(εv + s)
N
− η − u2 − μ − α
)
λ4 − (ηq + u2)λ5 − b2,
dλ5
dt
= −dH
dR
= −δλ1 − (−μ − δ)λ5.
Similarly by following the approach of Pontryagin et al. [15], to get the controls, we solved
the equation, ∂H/∂ui = 0 at u∗i , for i = 1, 2, 3 and obtained:
u∗1 =
ξ(ϒC + I)(ρV	λ3 − ρV	λ4 + ρSλ3 − ρSλ4 + V	λ4 − Sλ1 + Sλ4 − Vλ2)
Nw1
,
u∗2 = −
I(ηqλ3 − ηλ3 − λ4 + λ5)
w2
,
u∗3 =
C(λ3 − λ4)
w3
.
When we write by using standard control arguments involving the bounds on the controls,
we conclude
u∗1 =
⎧⎪⎨
⎪⎩
1 if 0 < 1 < 1,
0 if 1 ≤ 0,
1 if 1 ≥ 1.
u∗2 =
⎧⎪⎨
⎪⎩
2 if 0 < 2 < 1,
0 if 2 ≤ 0,
1 if 2 ≥ 1.
u∗3 =
⎧⎪⎨
⎪⎩
3 if 0 < 3 < 1,
0 if 3 ≤ 0,
1 if 3 ≥ 1.
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In compact notation
u∗1(t) = max{0,min(1,1)},
u∗2(t) = max{0,min(1,2)},
u∗3(t) = max{0,min(1,3)},
1 = ξ(ϒC + I)(ρV	λ3 − ρV	λ4 + ρSλ3 − ρSλ4 + V	λ4 − Sλ1 + Sλ4 − Vλ2)Nw1 ,
2 = − I(ηqλ3 − ηλ3 − λ4 + λ5)w2 ,
3 = C(λ3 − λ4)w3 .
The optimality system is formed from the optimal control system (the state system) and
the adjoint variable system by incorporating the characterized control set and initial and
transversal condition.
dS
dt
= (1 − p)π + φV + δR − (1 − u1
∗)ξ(ϒC + I)S
N
− (ϑ + μ)S,
dV
dt
== pπ + ϑS − (1 − u1
∗)ξ(ϒC + I)V
N
− (μ + φ)V ,
dC
dt
== ρ(1 − u1
∗)ξ(ϒC + I)(εV + S)
N
+ (1 − q)(1 − u2∗)ηI − (u3∗ + χ)C − (μ + β)C,
dI
dt
== (1 − ρ)(1 − u1
∗)ξ(ϒC + I)(εV + S)
N
+ (u3∗ + χ)C − (η + u2∗)I − (μ + α)I,
dR
dt
= βC + (u2∗ + qη)I − (μ + δ)R,
dλ1
dt
= −
(
− (1 − u1
∗)ξ(ϒC + I)
N
− ϑ − μ
)
λ1 − ϑλ2 − ρ(1 − u1
∗)ξ(ϒC + I)λ3
N
− (1 − ρ)(1 − u1
∗)ξ(ϒC + I)λ4
N
,
dλ2
dt
= −φλ1 −
(
− (1 − u1
∗)ξ(ϒC + I)
N
− μ − φ
)
λ2 − ρ(1 − u1
∗)ξ(ϒC + I)ελ3
N
− (1 − ρ)(1 − u1
∗)ξ(ϒC + I)	λ4
N
,
dλ3
dt
= (1 − u1
∗)ξϒSλ1
N
+ (1 − u1
∗)ξϒVλ2
N
−
(
ρ(1 − u1∗)ξϒ(	V + S)
N
− u3∗ − χ − μ − β
)
λ3
−
(
(1 − ρ)(1 − u1∗)ξϒ(	V + S)
N
+ u3∗ + χ
)
λ4 − βλ5 − b1,
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dλ4
dt
= (1 − u1
∗)ξSλ1
N
+ (1 − u1
∗)ξVλ2
N
−
(
ρ(1 − u1∗)ξ(	V + S)
N
+ (1 − q)(1 − u2∗)η
)
λ3
−
(
(1 − ρ)(1 − u1∗)ξ(εV + S)
N
− η − u2∗ − μ − α
)
λ4 − (ηq + u2)λ5 − b2,
dλ5
dt
= −δλ1 − (−μ − δ)λ5,
λi(tf ) = 0, i = 1, 2, 3, S(0) = S0, V(0) = V0, C(0) = C0,
I(0) = I0, and R(0) = R0. 
5.2. Uniqueness of the optimality system
Due to the priori boundedness of the state, adjoint functions and the resulting Lipschitz
structure of the ODEs, we can obtain the uniqueness of solutions of the optimality system
for the small time interval. Hence the following theorem.
Theorem 5.2: For t ∈ [0, tf ], the bounded solutions to the optimality system are unique.
For the proof of the theorem, see [2].
6. Numerical simulations
In this section, we perform some numerical experimentation on the basic model (1) and
the resulting optimality system consisting of the state equations (16) and the adjoint
system (18). We make use of the parameter values given in Table 2 for the simulation.
An iterative scheme is used to find the optimal solution of the optimality system. Since
the state system (1) has initial conditions and the adjoint systems (18) have final conditions,
we solve the state system using a forward fourth-order Runge–Kutta method and solve the
adjoint system using a backward fourth-order Runge–Kutta method. The solution iterative
scheme involves making a guess of the controls and using that guess to solve the state sys-
tem. The initial guess of the control together with the solution of the state systems is used
to solve the adjoint systems. The controls are then updated using a convex combination
of the previous controls and the values obtained using the characterizations. The updated
controls are then used to repeat the solution of the state and adjoint systems. This process is
repeated until the values in the current iteration are close enough to the previous iteration
values [7].
Using different combinations of the controls, such as one control only at a time, two
controls at a time and also all controls at a time, that we analyse and compare numerical
results from simulations with the following scenarios.
(i) Using Prevention effort (u1) of susceptible without treatment (u2 = 0) and with no
screening (u3 = 0).
(ii) Using treatment effort (u2) without prevention (u1 = 0) and with no screening
(u3 = 0).
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Figure 3. Simulations of optimal control with prevention only.
(iii) Using screening (u3) but without prevention (u1 = 0) and no treatment of infectious
u2 = 0.
(iv) Using prevention (u1) and treatment (u2) and without screening (u3 = 0).
(v) Using prevention u1 and screening (u3) and without treatment (u2 = 0).
(vi) Using treatment (u2) and screening u3 and without prevention (u1).
(vii) Using all the three controls, prevention u1 treatment of infective (u2) and screening
of carriers u3.
Weused b1 = 300, b2 = 150, w1 = 2, w2 = 2 andw3 = 6 for simulation of Pneumonia
model with optimal control and also for cost-effectiveness analysis. Additionally, we used
S(0) = 8200, V(0) = 2800, C(0) = 200, I(0) = 210, R(0) = 200 as initial values.
6.1. Control with prevention only
We simulate the model by preventive intervention only. From Figure 3, we see that the
decrease of infectious and carrier population due to implementation of prevention. This
can be attribute the fact that prevention minimizes the rate of joining of individuals in to
infective as well as carrier compartments. This implies that optimized prevention reduces
the burden of the infection of pneumonia.
6.2. Control with treatment only
Figure 4 shows a decrease of infectious population up to 4 month, then after start to go
up. Those individuals, who were previously with the disease are being treated and that is
why the number of infective population goes down for the first four months. Then, due
to lack of prevention newly infected individuals start to join the infective as well as the
carrier classes. That is why the number of infective start to goes up after four months of
going down and the number of carrier also starts to go up after five months.
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Figure 4. Simulations optimal control with treatment only.
Figure 5. Simulations of optimal control with screening only.
6.3. Control with screening only
Screening helps carriers to move into the infective classes and start to get treatment.
Figure 5 shows a decrease in carrier population up to fivemonths and then start to increase
because due to lack of prevention. Susceptible start to be infected and joins carrier as well
as infective classes. As a result of this screening only might not be sufficient to eradicate
the burden of the infection of pneumonia.
6.4. Control with prevention and treatment
We used prevention and treatment as intervention strategy, and Figure 7 show that, the
number of infective and also carriers goes down in the specified time. Therefore, this
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Figure 6. Simulations optimal control with prevention and treatment interventions.
Figure 7. Simulations of optimal control with prevention and screening intervention.
strategies is effective in eradicating the disease from the community in a specified period
of time (Figure 6).
6.5. Control with prevention and screening
In this strategy we used prevention and screening. The first Figure 7 shows that the curve
for optimal control is above the curve of with out control. Due to the reason that there
is no treatment but individuals from carrier groups are joining infective compartment by
screening and also there are a number of infected people in the compartment before pre-
vention with out getting treatment so this situation make the curve to goes up for a time
being. After some time the number of infectious goes down because due to prevention
422 G. T. TILAHUN ET AL.
Figure 8. Simulations of optimal control with treatment and screening intervention.
strategies, new infection is no more coming and also since there is no treatment the num-
ber of infective population start to goes down by disease causing death and natural death
rates.
6.6. Control with treatment and screening
We used treatment and screening controls as intervention. From Figures 8, we observe
that optimal control of the combination of treatment and screening helps to bring down
the infectious as well as the carrier population which helps to eradicate the disease in the
community.
6.7. Control with prevention, treatment and screening
We implement all control the three controls interventions that helps tominimize the objec-
tive function. From Figure 9, we observe that the number of the infectious and carrier
populations decrease at the specified time due to the intervention strategies. Therefore,
applying this strategy helps to eradicate pneumonia disease in specified period of time
(Figure 10).
7. Cost-effectiveness analysis
Cost-effectiveness analysis used to rank the implemented strategies interims of their cost.
Applying one intervention onlymight to be effective to eradicate the disease from the com-
munity. Therefore, we analysed strategies that used more than one intervention method.
To achieve, this we used incremental cost-effectiveness ratio (ICER), stated by Baba and
Makinde [1];
“ICER = Difference in costs between strategies
Difference in health effects between strategies
.′′
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Figure 9. Simulations of optimal control with Prevention, Treatment and screening interventions.
Figure 10. Backward bifurcation of the force of infection at equilibrium against the eﬀective reproduc-
tion number Reﬀ.
In Table 3 we obtain the total number of infectious averted and total cost for the imple-
mented strategies. The difference between the total infectious individuals without control
and the total infectious individuals with control is used to obtain the total number of infec-
tious averted. And also to find the total cost for the implemented strategies we used the
cost function, which is 12w1u
2
1,
1
2w2u
2
2 and
1
2w3u
2
3 over time. We used the parameter val-
ues in Table 2 and to apply ICER technique first we ordered the intervention strategies for
pairwise comparison as in Table 2 from A to D with increasing order of effectiveness.
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Table 3. Number of infectious averted and total cost of each strategies.
Strategies Description Total infectious averted Total cost (USD)
A Vaccination and screening 101,417 5906.1
B Treatment and screening 116,099 5472.7
C Prevention and treatment 117,142 5292
D Prevention, treatment and screening 119,465 6948.8
Figure 11. Cost Function of the intervention strategies for the period of 10 months.
First, we compared the cost effectiveness of strategy A and B.
ICER(A) = 5, 906.1
101, 417
= 0.058,
ICER(B) = 5, 472.7 − 5, 906.1
116, 099 − 101, 417 = −0.029.
From ICER (A) and ICER (B), we can see that strategy B saves 0.029 than strategy A.
Therefore, we exclude strategy A, because it is a bit expensive continue to compare strategy
B and C.
ICER(B) = 5, 472.7
116, 099
= 0.047,
ICER(C) = 5, 292 − 5, 472.7
117, 142 − 116, 099 = −0.0015.
Similarly, from ICER (B) and ICER (C)we can see that strategyC saves 0.0015 than strategy
B. Therefore, we exclude strategy B, because it is a bit expensive and finally, we compared
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strategy C and D.
ICER(C) = 5, 292
117, 142
= 0.045,
ICER(D) = 6, 948.8 − 5, 292
119, 465 − 117, 142 = 0.71.
From ICER (C) and ICER (D) we can see that strategy C saves 0.71 than strategy D. There-
fore, we exclude strategy D, because it is a bit expensive. Therefore, we conclude that
strategy C the cheapest of all compared strategies, that meant it is the most cost-effective
for pneumonia disease control interventions strategy’s.
For further elaboration, Figure 11 shows that applying only one intervention costs the
least interims of price but we did not consider this, due to the reason that a single inter-
vention is not effective to eradicate the disease. And additionally we observe from the
figure, applying all the three intervention at once is the most expensive of all the applied
intervention strategies.
8. Discussions and conclusions
In Section 2 we described and proposed a pneumonia model, which is deterministic in its
nature and also the population is assumed to be variable in size. In Section 3 we analysed
the model by obtaining the feasible region, positivity of the solution set, effective repro-
ductive number, equilibria points and their stability.Moreover, we described the possibility
of backward bifurcation in Section 3. In Section 4, sensitivity analysis and interpretation
of the sensitivity index is done. In Section 5 we extended the model by applying optimal
control interventions and we obtained the Hamiltonian, the adjoint variables, the charac-
terization of the controls and the optimality system. In Section 6 we the optimality system
by considering different strategies as follows:
• By applying a single control, prevention, treatment or screening.
• By applying two control, prevention and treatment.
• By applying two control, prevention and screening.
• By applying two control, treatment and screening.
• By applying all control, prevention, treatment and screening.
In Section 7 numerically we investigated cost effectiveness to determine, the least and
themost expensive strategies by using ICER. From the pairwise result in this study, we con-
clude that, the combination of prevention and treatment is the best cost-effective strategies
interims of cost as well as health benefits.
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